Absence of immunostaining for growth hormone in a subset of patients with acromegaly

Author： Schroeder Jason   Spiotta Alejandro   Fleseriu Maria   Prayson Richard   Hamrahian Amir   Weil Robert  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.17, Iss.2, 2014-04, pp. : 103-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Growth hormone measurements in the diagnosis and monitoring of acromegaly

By Sata Akira   Ho Ken  

Pituitary, Vol. 10, Iss. 2, 2007-06 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly

By Bianchi Antonio   Mazziotti Gherardo   Tilaro Laura   Cimino Vincenzo   Veltri Flora   Gaetani Eleonora   Pecorini Giovanni   Pontecorvi Alfredo   Giustina Andrea   Marinis Laura  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 196-199

Springer Publishing Company

Access to resources Recommend Favorite

Acromegaly Secondary to Growth Hormone-releasing Hormone Secreted by an Incidentally Discovered Pheochromocytoma

By Vieira Neto L.   Taboada G.   Corrêa L.   Polo J.   Nascimento A.   Chimelli L.   Rumilla K.   Gadelha M.  

Endocrine Pathology, Vol. 18, Iss. 1, 2007-05 ,pp. : 46-52

Humana Press, Inc

Access to resources Recommend Favorite

Quantification of day-to-day variability in growth hormone levels in acromegaly

By Kraftson Andrew  

Pituitary, Vol. 13, Iss. 4, 2010-12 ,pp. : 351-354

Springer Publishing Company

Access to resources Recommend Favorite

Clinical use of a growth hormone receptor antagonist in the treatment of acromegaly

By Drake W.M.   Parkinson C.   Besser G.M.   Trainer P.J.  

Trends in Endocrinology and Metabolism, Vol. 12, Iss. 9, 2001-11 ,pp. : 408-413

Elsevier

Access to resources Recommend Favorite